Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Expert Opin Drug Deliv. 2020 Feb 19;17(4):439–461. doi: 10.1080/17425247.2020.1729119

Figure 3.

Figure 3.

(a) Schematic representation of the prostacyclin pathway, (b) Schematic representation of the guanosine monophosphate (GMP) and nitric oxide pathways., (c) Schematic representation of the endothelin system in vascular tissue. (d) Mechanisms through which current drugs elicit pulmonary vasodilatation to treat pulmonary hypertension.